177 related articles for article (PubMed ID: 18191881)
1. Willingness of Chinese injection drug users to participate in HIV vaccine trials.
Yin L; Zhang Y; Qian HZ; Rui B; Zhang L; Zhu J; Guan Y; Wang Y; Li Q; Ruan Y; Shao Y
Vaccine; 2008 Feb; 26(6):762-8. PubMed ID: 18191881
[TBL] [Abstract][Full Text] [Related]
2. Willingness to participate in HIV vaccine clinical trials among Chinese men who have sex with men.
Li Q; Luo F; Zhou Z; Li S; Liu Y; Li D; Shi W; Raymond HF; Ruan Y; Shao Y
Vaccine; 2010 Jun; 28(29):4638-43. PubMed ID: 20452428
[TBL] [Abstract][Full Text] [Related]
3. Changes in willingness to participate in HIV vaccine trials among HIV-negative injection drug users.
Golub ET; Purvis LA; Sapun M; Safaeian M; Beyrer C; Vlahov D; Strathdee SA
AIDS Behav; 2005 Sep; 9(3):301-9. PubMed ID: 16088366
[TBL] [Abstract][Full Text] [Related]
4. Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.
O'Connell JM; Hogg RS; Chan K; Strathdee SA; McLean N; Martindale SL; Willoughby B; Remis R
J Acquir Immune Defic Syndr; 2002 Dec; 31(5):521-8. PubMed ID: 12473841
[TBL] [Abstract][Full Text] [Related]
5. Dual HIV risk: receptive syringe sharing and unprotected sex among HIV-negative injection drug users in New York City.
Neaigus A; Reilly KH; Jenness SM; Hagan H; Wendel T; Gelpi-Acosta C
AIDS Behav; 2013 Sep; 17(7):2501-9. PubMed ID: 23640654
[TBL] [Abstract][Full Text] [Related]
6. Willingness to participate in HIV therapeutic vaccine trials among HIV-infected patients on ART in China.
Dong Y; Shen X; Guo R; Liu B; Zhu L; Wang J; Zhang L; Sun J; Zhang X; Xu J
PLoS One; 2014; 9(11):e111321. PubMed ID: 25372044
[TBL] [Abstract][Full Text] [Related]
7. Pilot study assessing HIV vaccine trial readiness among female sex workers, injection and non-injection drug users, and men who have sex with men in Spain.
Etcheverry MF; de Lazzari E; Fuchs JD; Meroño M; Sierra E; Del Romero J; Evans JL; Mendez-Arancibia E; Jacques C; Rojas D; Segú M; Gatell JM; Joseph J
AIDS Behav; 2010 Jun; 14(3):607-17. PubMed ID: 19037720
[TBL] [Abstract][Full Text] [Related]
8. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
[TBL] [Abstract][Full Text] [Related]
9. Gender and HIV risk behavior among intravenous drug users in Sichuan Province, China.
Choi SY; Cheung YW; Chen K
Soc Sci Med; 2006 Apr; 62(7):1672-84. PubMed ID: 16185801
[TBL] [Abstract][Full Text] [Related]
10. Correlates of shared methamphetamine injection among methamphetamine-injecting treatment seekers: the first report from Iran.
Mehrjerdi ZA; Abarashi Z; Noroozi A; Arshad L; Zarghami M
Int J STD AIDS; 2014 May; 25(6):420-7. PubMed ID: 24287028
[TBL] [Abstract][Full Text] [Related]
11. Will preventive HIV vaccine efficacy trials be possible with female injection drug users?
Meyers K; Metzger DS; McLellan AT; Navaline H; Sheon AR; Woody GE
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(5):577-85. PubMed ID: 8548338
[TBL] [Abstract][Full Text] [Related]
12. Preparations for AIDS vaccine trials. Retention, behavior change, and HIV-seroconversion among injecting drug users (IDUs) and sexual partners of IDUs.
Marmor M; Titus S; Wolfe H; Krasinski K; Maslansky R; Simberkoff M; Beatrice S; Nichols S; Des Jarlais DC
AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S207-13. PubMed ID: 7865302
[TBL] [Abstract][Full Text] [Related]
13. Willingness of injection drug users to participate in an HIV vaccine efficacy trial in Bangkok, Thailand.
MacQueen KM; Vanichseni S; Kitayaporn D; Lin LS; Buavirat A; Naiwatanakul T; Raktham S; Mock P; Heyward WL; Des Jarlais DC; Choopanya K; Mastro TD
J Acquir Immune Defic Syndr; 1999 Jul; 21(3):243-51. PubMed ID: 10421249
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and correlates of willingness to participate in a rectal microbicide trial among men who have sex with men in Bangkok.
Thienkrua W; Todd CS; Chaikummao S; Sukwicha W; Yafant S; Tippanont N; Varangrat A; Khlaimanee P; Holtz TH
AIDS Care; 2014; 26(11):1359-69. PubMed ID: 24797186
[TBL] [Abstract][Full Text] [Related]
15. A cross-sectional study on factors including HIV testing and counselling determining unsafe injecting practices among injecting drug users of Manipur.
Sarkar S; Panda S; Sarkar K; Hangzo CZ; Bijaya L; Singh NY; Das N; Agarwal A; Chatterjee A; Deb BC
Indian J Public Health; 1995; 39(3):86-92. PubMed ID: 8690497
[TBL] [Abstract][Full Text] [Related]
16. Willingness to Participate in Hypothetical HIV Vaccine Trial and Associated Factors among People Who Inject Drugs in Dar es Salaam, Tanzania.
Iseselo MK; Tarimo EAM; Sandstrom E; Kulane A
Biomed Res Int; 2020; 2020():8507981. PubMed ID: 32714988
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with willingness to participate in HIV vaccine trials among high-risk populations in South India.
Suhadev M; Nyamathi AM; Swaminathan S; Suresh A; Venkatesan P
AIDS Res Hum Retroviruses; 2009 Feb; 25(2):217-24. PubMed ID: 19239362
[TBL] [Abstract][Full Text] [Related]
18. Acceptability of human papillomavirus vaccine among parents of junior middle school students in Jinan, China.
Wang W; Ma Y; Wang X; Zou H; Zhao F; Wang S; Zhang S; Zhao Y; Marley G; Ma W
Vaccine; 2015 May; 33(22):2570-6. PubMed ID: 25887088
[TBL] [Abstract][Full Text] [Related]
19. Who will enroll? Predicting participation in a phase II AIDS vaccine trial.
Halpern SD; Metzger DS; Berlin JA; Ubel PA
J Acquir Immune Defic Syndr; 2001 Jul; 27(3):281-8. PubMed ID: 11464149
[TBL] [Abstract][Full Text] [Related]
20. Relationship-level analysis of drug users' anticipated changes in risk behavior following HIV vaccination.
Young AM; Halgin DS; Havens JR
AIDS Care; 2015; 27(8):1000-4. PubMed ID: 25730519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
